| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/20/2001 | WO2001096335A1 Imidazo[1,2-a]pyridine ether compounds as ion channel modulators |
| 12/20/2001 | WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096331A1 Lactam inhibitors of factor xa and method |
| 12/20/2001 | WO2001096330A2 Thrombin receptor antagonists |
| 12/20/2001 | WO2001096328A1 Indole derivatives useful for the treatment of cns disorders |
| 12/20/2001 | WO2001096327A1 BIOISOSTERIC BENZAMIDE DERIVATIVES AND THEIR USE AS APoB-100 SECRETION INHIBITORS |
| 12/20/2001 | WO2001096323A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096314A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 12/20/2001 | WO2001096311A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 12/20/2001 | WO2001096310A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists |
| 12/20/2001 | WO2001096307A2 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096305A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096304A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096302A1 Piperidines for use as orexin receptor antagonists |
| 12/20/2001 | WO2001096300A1 Growth hormone secretagogues |
| 12/20/2001 | WO2001096299A2 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 12/20/2001 | WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
| 12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | WO2001096296A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096295A2 2-cyanopyrrolidine derivatives and their use as medicaments |
| 12/20/2001 | WO2001096293A1 Vitamin d derivatives |
| 12/20/2001 | WO2001096289A1 Sulfonamide derivatives |
| 12/20/2001 | WO2001096286A2 Urokinase inhibitors |
| 12/20/2001 | WO2001096285A1 Beta-amino acid nitrile derivatives |
| 12/20/2001 | WO2001096283A2 Hiv integrase inhibitors |
| 12/20/2001 | WO2001096281A1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 12/20/2001 | WO2001096279A1 Shortened synthesis of 3,3-diarylpropylamine derivatives |
| 12/20/2001 | WO2001095946A2 Combination product for carrying out a cytotoxic treatment in a mammal |
| 12/20/2001 | WO2001095945A2 Prodrug compounds cleavable by thimet oligopeptidase |
| 12/20/2001 | WO2001095939A1 Novel solid dispersion compositions |
| 12/20/2001 | WO2001095938A1 Preventives/remedies for granuloma |
| 12/20/2001 | WO2001095937A2 Phytoestrogenic isoflavone compositions |
| 12/20/2001 | WO2001095936A2 Monoterpenes and sesquiterpenes as radiation sensitizers |
| 12/20/2001 | WO2001095930A1 Method of photoreduction of hemoglobin vesicles |
| 12/20/2001 | WO2001095925A1 Pharmaceutical anti-inflammatory aerosol formulation |
| 12/20/2001 | WO2001095923A1 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root |
| 12/20/2001 | WO2001095921A1 Cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials |
| 12/20/2001 | WO2001095920A1 Composition comprising clinoptolite, plant extracts and vitamin b complex for diabetic neuropathy |
| 12/20/2001 | WO2001095916A2 Anticholestatic medicament containing luteolin-7-o-glucuronide |
| 12/20/2001 | WO2001095914A1 Lipids for modulating immune response |
| 12/20/2001 | WO2001095913A1 Methods and compositions for the prevention of myopia |
| 12/20/2001 | WO2001095912A1 COMPOSITIONS CONTROLLING RELEASE pH RANGE AND/OR SPEED |
| 12/20/2001 | WO2001095911A1 Protease inhibitors |
| 12/20/2001 | WO2001095910A1 Imidazopyridine and imidazopyrimidine antiviral agents |
| 12/20/2001 | WO2001095909A1 New use as antihelmintics of albofungin and analogs |
| 12/20/2001 | WO2001095908A1 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
| 12/20/2001 | WO2001095907A1 Pharmaceutical composition for the treatment of multiple sclerosis |
| 12/20/2001 | WO2001095906A1 Treatment and prevention of cardiac insulin resistance associated conditions |
| 12/20/2001 | WO2001095905A1 Inhibitor for enzyme having two divalent metal ions as active centers |
| 12/20/2001 | WO2001095904A1 Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist |
| 12/20/2001 | WO2001095903A1 5-ht3 receptor antagonists for treatment of disorders involving airway constriction |
| 12/20/2001 | WO2001095902A1 A composition comprising a combination of receptor agonists and antagonists |
| 12/20/2001 | WO2001095901A1 Radioprotective agents |
| 12/20/2001 | WO2001095900A1 Pharmaceutical disinfectants comprising usnic and essential oils |
| 12/20/2001 | WO2001095899A2 Pharmaceutical compositions comprising cannabidiol derivatives |
| 12/20/2001 | WO2001095898A1 Analgesic and anti-inflammatory compositions containing cox-2 inhibitors |
| 12/20/2001 | WO2001095897A1 Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders |
| 12/20/2001 | WO2001095896A2 Protein phosphatase 2a inhibitors to inhibit host-cell mediated viral replication |
| 12/20/2001 | WO2001095895A2 Methods of potentiating organic nitrates having vasodilating activity and formulations for the same |
| 12/20/2001 | WO2001095894A2 Topical water-based anti-inflammatory compositions |
| 12/20/2001 | WO2001095893A1 Use of an epoxy-steroidal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 12/20/2001 | WO2001095892A1 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects |
| 12/20/2001 | WO2001095891A2 Method for treating dehydration and a composition therefor |
| 12/20/2001 | WO2001095890A2 Oral pharmaceutical compositions containing terbinafine |
| 12/20/2001 | WO2001095887A1 Solid, orally administered, water-dispersible pharmaceutical form for the treatment of tuberculosis, containing rifampicin, isoniazid, pirazinamide and pyridoxine hydrochloride, method for obtaining and presentation form of said pharmaceutical form |
| 12/20/2001 | WO2001095886A1 Bioavailable dosage form of isotretinoin |
| 12/20/2001 | WO2001095885A1 Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrin antagonist |
| 12/20/2001 | WO2001095884A2 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations |
| 12/20/2001 | WO2001095883A1 Novel pharmaceutical formulation suitable for nebulisation |
| 12/20/2001 | WO2001095881A1 Pharmaceutical anti-inflammatory aerosol formulation |
| 12/20/2001 | WO2001095880A1 Novel pharmaceutical formulation suitable for nebulisation |
| 12/20/2001 | WO2001095879A1 Novel aqueous anti-inflammatory pharmaceutical formulation |
| 12/20/2001 | WO2001095878A1 Process for the preparation of a sterile ointment containing acyclovir |
| 12/20/2001 | WO2001095877A2 Porous celecoxib matrices and methods of manufacture thereof |
| 12/20/2001 | WO2001095874A2 Highly efficient delivery of a large therapeutic mass aerosol |
| 12/20/2001 | WO2001095872A1 Cosmetic and/or dermatological composition based on cocoa extracts |
| 12/20/2001 | WO2001095859A2 Novel heterocyclic analogs of diphenylethylene compounds |
| 12/20/2001 | WO2001095858A2 Piperazinedione compounds |
| 12/20/2001 | WO2001095746A1 Compositions for taking dietary fibers |
| 12/20/2001 | WO2001095727A1 Phytonutrient formula for the relief of chronic pain resulting from inflammation |
| 12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/20/2001 | WO2001078725A3 Modified release formulations containing a hypnotic agent |
| 12/20/2001 | WO2001074788A8 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 12/20/2001 | WO2001074396A8 Composition and method for promoting oral health |
| 12/20/2001 | WO2001070154A9 Device and method for treating urinary incontinence in females |
| 12/20/2001 | WO2001066550A3 Compounds for pdt |
| 12/20/2001 | WO2001066102A3 Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same |
| 12/20/2001 | WO2001064192A3 Use of benzothieno-2,3-d-pyrimidines with pde v inhibitory effect for the treatment of erectile dysfunction |
| 12/20/2001 | WO2001064164A3 Nanocapsule encapsulation system and method |
| 12/20/2001 | WO2001062933A3 Muteins of interleukin-13 (il-13) |
| 12/20/2001 | WO2001062245A3 Bilirubin or biliverdin degradation fragments |
| 12/20/2001 | WO2001062207A3 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 12/20/2001 | WO2001059128A3 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 12/20/2001 | WO2001059100A3 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 12/20/2001 | WO2001058896A8 Benzoxazole derivatives as tnf and pde iv inhibitors |
| 12/20/2001 | WO2001056554A3 Use of retinoid-type compounds as antibacterial agents |
| 12/20/2001 | WO2001055108A3 Use of spl a2 inhibitors for the treatment of inflammation |
| 12/20/2001 | WO2001052874A3 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 12/20/2001 | WO2001052835A3 Free radical scavengers for the treatment of premature birth |